Results 111 to 120 of about 76,921 (190)

Discriminating between proposed Brain-First and Body-First Parkinson’s disease using conventional and radiomics-enhanced dopamine transporter SPECT image analysis

npj Parkinson's Disease
Two Parkinson’s disease subtypes—“Brain-First” and “Body-First”—have been proposed based on putative sites of onset. We examined whether “Body-First” markers relate to more symmetric striatal [123I]-FP-CIT uptake and whether imaging could discriminate ...
Giovanni Palermo, Gayanè Aghakhanyan, Gabriele Bellini, Sara Giannoni, Gabriele Vadi, Roberto Francischello, Giovanna Nonne, Maria Giulia Tedeschi, Riccardo Morganti, Daniela Frosini, Nicola Pavese, Duccio Volterrani, Roberto Ceravolo   +12 more
doaj   +1 more source

Cardiocerebral hemodynamic characteristics of vasovagal syncope associated with cerebral autoregulation impairment

Frontiers in Neurology
BackgroundIt is generally believed that cerebral hypoperfusion in patients with vasovagal syncope (VVS) is secondary to hypotension; however, current evidence suggests that this is not always the case.
Meng Hou, Meng Hou, Jingke Le, Lijie Ren, Lijie Ren, Liming Cao, Liming Cao   +6 more
doaj   +1 more source

Norepinephrine reuptake blockade to treat neurogenic orthostatic hypotension. [PDF]

Clin Auton Res, 2021
Eisenhofer G, Goldstein DS.
europepmc   +1 more source

Treatment of Neurogenic Orthostatic Hypotension [PDF]

Research in Vestibular Science, 2017
Jung-Ick Byun, Sang Beom Kim
openaire   +1 more source

Bridging the autonomic divide: Closed-loop spinal cord stimulation as a dynamic therapy for parkinsonian orthostatic hypotension

Therapeutic Advances in Neurological Disorders
Neurogenic orthostatic hypotension (nOH) in Parkinson’s disease (PD) represents a potential “central-peripheral disconnection” rather than an isolated peripheral deficit.
Jing Zhao, ZiBin Ma, ZiXin Chia, Xinyue Wang, Chong Shi, Jia Chen, Di Jin, Shaochen Ma, Xiaoyun Zhang, Jiaqi Chen, Yanuo Wei, Tianjiao Ren, Peifu Wang, Jilai Li, Jing Yang, Jichen Du, Zhirong Wan   +16 more
doaj   +1 more source

Predictors of the Pressor Response to the Norepinephrine Transporter Inhibitor, Atomoxetine, in Neurogenic Orthostatic Hypotension. [PDF]

Hypertension, 2021
Shibao CA, Palma JA, Celedonio JE, Martinez J, Kaufmann H, Biaggioni I.   +5 more
europepmc   +1 more source

Effects of Atomoxetine for the Treatment of Neurogenic Orthostatic Hypotension in Patients With Alpha-synucleinopathies: A Systematic Review of Randomized Controlled Trials and a Focus-Group Discussion. [PDF]

J Clin Neurol, 2023
Jung YJ, Kim A, Okamoto LE, Hong WH.
europepmc   +1 more source

Neurogenic orthostatic hypotension with Parkinson's disease as a cause of syncope: A case report. [PDF]

World J Clin Cases, 2021
Li Y, Wang M, Liu XL, Ren YF, Zhang WB.
europepmc   +1 more source

Management of Neurogenic Orthostatic Hypotension in Neurodegenerative Disorders: A Collaboration Between Cardiology and Neurology. [PDF]

Neurol Ther, 2021
Amjad FS, Beinart SC.
europepmc   +1 more source

Safety and efficacy of ampreloxetine in symptomatic neurogenic orthostatic hypotension: a phase 2 trial. [PDF]

Clin Auton Res, 2021
Kaufmann H, Vickery R, Wang W, Kanodia J, Shibao CA, Norcliffe-Kaufmann L, Haumann B, Biaggioni I.   +7 more
europepmc   +1 more source